Mark A. Gohr
Finanzdirektor/CFO bei ANTH1, Inc.
Ursprung des Netzwerks ersten Grades von Mark A. Gohr
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
ANTH1, Inc.
ANTH1, Inc. Pharmaceuticals: MajorHealth Technology ANTH1, Inc. operates as a development stage company. It is a biotechnology company dedicated to developing vaccines for several infectious diseases including H5N1 influenza virus. The firm utilizes state of the art recombinant DNA adenoviral vector and Rnai (inhibition RNA) technologies to develop highly specific genetic vaccines. The company was founded on September 10, 2007 and is headquartered in Conifer, CO.
3
| Private Company | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Mark A. Gohr
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
University of Illinois | College/University | Undergraduate Degree | |
The University of Colorado | College/University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 3 |
Sektoral
Consumer Services | 3 |
Operativ
President | 2 |
Undergraduate Degree | 2 |
Chief Executive Officer | 1 |
Corporate Secretary | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Jeffrey W. Villano | 2 |
James J. Tufts | 2 |
Larry A. Gelhaar | 1 |
- Börse
- Insiders
- Mark A. Gohr
- Unternehmensverbindungen